Biocon Limited — Important, 10-12-2024: General Updates

Biocon Limited sold 80,00,000 equity shares of Syngene International Limited through a block deal mechanism, reducing its stake to 52.46%. The transaction, completed on December 10, 2024, generated approximately ₹686 crore. This sale represents about 22.91% of Biocon's consolidated turnover and about 16.85% of its net worth, as per the last audited financial statements. The buyers do not belong to the promoter group, and the transaction is not classified as a related party transaction. Investors should consider this development for its potential impact on Biocon's financial position and strategic focus, monitoring any future implications closely.